ISPOR - PES3 PRIOR AUTHORIZATION OF TOPICAL RETINOIDS NEEDED? EVIDENCE FROM OUTPATIENT US NATIONAL PRACTICE DATA

Full Text

PES3 PRIOR AUTHORIZATION OF TOPICAL RETINOIDS NEEDED? EVIDENCE FROM OUTPATIENT US NATIONAL PRACTICE DATA

Abstract

Authors

R Balkrishnan R Shenolikar JC Sansbury S Feldman

Back to Volume 7, Issue 3

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now